Adam Good

Vice President Of Product Development at NeuBase Therapeutics - Pittsburgh, PA, US

Adam Good's Contact Details
HQ
N/A
Location
Company
NeuBase Therapeutics
Adam Good's Company Details
NeuBase Therapeutics logo, NeuBase Therapeutics contact details

NeuBase Therapeutics

Pittsburgh, PA, US • 50 - 99 Employees
Major Drugs

NeuBase is developing ultra precision genetic medicines targeting rare, monogenic diseases, for which there are no approved therapies, as well as more common genetic disorders, including cancers that are resistant to current therapeutic approaches. NeuBase's pipeline includes therapeutic candidates for the treatment of myotonic dystrophy type 1 (DM1), Huntington's disease (HD), and cancer-driving point mutations in KRAS G12V and G12D, which are involved in many tumor types and have historically been "undruggable."

Biotechnology Gene Silencing Antisense Oligonucleotide Therapies Rare Disease Genetic Disease Huntington's Disease Myotonic Dystrophy CNS Disease Huntington's Disease
Details about NeuBase Therapeutics
Frequently Asked Questions about Adam Good
Adam Good currently works for NeuBase Therapeutics, Inc..
Adam Good's role at NeuBase Therapeutics, Inc. is Vice President Of Product Development.
Adam Good's email address is ***@neubasetherapeutics.com. To view Adam Good's full email address, please signup to ConnectPlex.
Adam Good works in the Pharmaceuticals industry.
Adam Good's colleagues at NeuBase Therapeutics are Dani Stoltzfus, Dietrich Stephan, Barry Badeau, Ramesh Batwal, Zachary Miller, Rohan Kumbhare, Jessica Jeffers and others.
Adam Good's phone number is N/A
See more information about Adam Good